Chengdu Kanghong Pharmaceutical Group Co., Ltd.

This is an early safety study for a new pain medication called KHN702 tablets. It will test if the drug is safe and can help reduce moderate to severe pain in the first 48 hours after surgery. The study will involve 24 patients who will receive either the new drug or a placebo (a…